Related Experiment Video
Updated: Oct 9, 2025

07:23
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
2.9K
Establishment of a prediction tool for ocular trauma patients with machine learning algorithm
Seungkwon Choi1,2, Jungyul Park1,2, Sungwho Park1,2
1Department of Ophthalmology, Pusan National University Hospital, Busan 49241, Republic of Korea.
International Journal of Ophthalmology
|December 20, 2021
Summary
This study developed a highly accurate machine learning model to predict final visual acuity in patients with open globe injury. Key factors like retinal detachment and initial visual acuity significantly influence prognosis, aiding clinical decision-making.
Area of Science:
- Ophthalmology
- Medical Informatics
- Machine Learning
Background:
- Open globe injury poses a significant threat to vision, necessitating accurate prognostic tools.
- Predicting final visual acuity is crucial for patient management and treatment planning.
Purpose of the Study:
- To develop and validate a highly accurate predictive model for final visual acuity in open globe injury patients.
- To identify key factors influencing the prognosis of open globe injuries.
Main Methods:
- A retrospective review of 171 open globe injury patients' data was conducted.
- Supervised classification algorithms, including a two-class boosted decision tree, were employed using Microsoft Azure Machine Learning Studio.
- Cross-validation, permutation feature importance, and synthetic minority over-sampling technique were utilized to enhance model performance.
Main Results:
- The two-class boosted decision tree model achieved high predictive performance (accuracy: 0.925, AUC: 0.971).
- The top 14 prognostic factors identified include retinal detachment, laceration location, initial visual acuity, and iris damage.
- The model demonstrated strong accuracy, precision, recall, and F1 score.
Conclusions:
- A highly accurate and accessible model for predicting final visual acuity in open globe injury was developed.
- This prognostic tool can aid clinicians and patients, potentially reducing socioeconomic burden.
- Further multicenter validation is recommended for global applicability.

